Capital Research Global Investors’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.17B | Buy |
16,108,291
+1,571,947
| +11% | +$700M | 1.44% | 15 |
|
|
2025
Q1 | $7.05B | Buy |
14,536,344
+4,107,393
| +39% | +$1.99B | 1.53% | 13 |
|
|
2024
Q4 | $4.2B | Buy |
10,428,951
+1,426,746
| +16% | +$575M | 0.86% | 29 |
|
|
2024
Q3 | $4.19B | Buy |
9,002,205
+462,866
| +5% | +$215M | 0.87% | 31 |
|
|
2024
Q2 | $4B | Buy |
8,539,339
+2,795,457
| +49% | +$1.31B | 0.88% | 27 |
|
|
2024
Q1 | $2.4B | Buy |
5,743,882
+2,176,218
| +61% | +$910M | 0.54% | 48 |
|
|
2023
Q4 | $1.45B | Buy |
3,567,664
+195,080
| +6% | +$79.4M | 0.36% | 74 |
|
|
2023
Q3 | $1.17B | Buy |
3,372,584
+310,908
| +10% | +$108M | 0.32% | 78 |
|
|
2023
Q2 | $1.08B | Buy |
3,061,676
+2,251,781
| +278% | +$792M | 0.29% | 83 |
|
|
2023
Q1 | $255M | Buy |
+809,895
| New | +$255M | 0.07% | 191 |
|
|
2020
Q4 | – | Sell |
-1,250,658
| Closed | -$340M | – | 433 |
|
|
2020
Q3 | $340M | Sell |
1,250,658
-1
| -0% | -$272 | 0.1% | 169 |
|
|
2020
Q2 | $363M | Sell |
1,250,659
-5
| -0% | -$1.45K | 0.11% | 152 |
|
|
2020
Q1 | $298M | Buy |
1,250,664
+15
| +0% | +$3.57K | 0.12% | 147 |
|
|
2019
Q4 | $274M | Buy |
1,250,649
+379
| +0% | +$83K | 0.08% | 192 |
|
|
2019
Q3 | $212M | Buy |
1,250,270
+22
| +0% | +$3.73K | 0.07% | 201 |
|
|
2019
Q2 | $229M | Buy |
1,250,248
+248
| +0% | +$45.5K | 0.07% | 191 |
|
|
2019
Q1 | $230M | Sell |
1,250,000
-815,018
| -39% | -$150M | 0.07% | 197 |
|
|
2018
Q4 | $342M | Sell |
2,065,018
-590,000
| -22% | -$97.8M | 0.12% | 158 |
|
|
2018
Q3 | $512M | Buy |
+2,655,018
| New | +$512M | 0.15% | 136 |
|